Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 3,376,100 | 3,681,600 | 3,534,300 | 3,671,301 | 3,600,100 |
| Cost of Goods | 449,100 | 411,100 | 454,300 | 447,100 | 430,000 |
| Gross Profit | 2,927,000 | 3,270,500 | 3,080,000 | 3,224,200 | 3,170,100 |
| Operating Expenses | 1,840,700 | 1,296,100 | 1,260,400 | 1,446,601 | 1,363,800 |
| Operating Income | 1,086,400 | 1,974,500 | 1,819,900 | 1,777,700 | 1,806,300 |
| Other Income | -141,700 | 78,100 | -135,300 | -61,900 | -49,100 |
| Pre-tax Income | 944,700 | 2,052,600 | 1,684,600 | 1,715,800 | 1,757,200 |
| Income Tax | 240,800 | 446,100 | 292,000 | 276,100 | 211,300 |
| Net Income Continuous | 703,900 | 1,606,500 | 1,392,600 | 1,439,700 | 1,545,900 |
| Minority Interests | 2,400 | 64,400 | -6,500 | N/A | N/A |
| Net Income | $701,500 | $1,542,100 | $1,399,100 | $1,439,700 | $1,545,900 |
| EPS Basic Total Ops | 4.47 | 9.60 | 8.10 | 8.05 | 8.40 |
| EPS Basic Continuous Ops | 4.49 | 10.00 | 8.06 | 8.05 | 8.40 |
| EPS Diluted Total Ops | 4.46 | 9.59 | 8.08 | 8.03 | 8.39 |
| EPS Diluted Continuous Ops | 4.48 | 9.98 | 8.05 | 8.03 | 8.39 |
| EBITDA(a) | $1,220,400 | $2,087,400 | $1,939,800 | $1,890,699 | $2,135,800 |